Articles

Expert testifies NCAA scholarship caps hurt competition

The National Collegiate Athletic Association stifles competition among schools for players by capping scholarships, a Stanford University professor said Tuesday at a trial in which athletes are seeking a cut of the billions of dollars generated by college sports.

Read More

Ponzi scheme leader gets 10 years in prison

Rudolf “Rudi” Pameijer, a former Johnson County insurance agent who pleaded guilty to scamming $1.8 million from two dozen investors, was sentenced Monday to 18 years in prison, with eight of those years suspended.

Read More

Adviser who swindled Ball State out of $8M gets 4 years

Seth Beoku Betts persuaded the university to give him money to invest in collateralized mortgage obligations. His attorney say he lost the money through bad investments, but prosecutors say he spent much of it on himself, including buying a $1.5 million home in Florida.

Read More

Not-for-profit leader faces tax evasion, perjury charges

Byron Alston, a high-profile employee of the anti-crime Ten Point Coalition and founder of the not-for-profit group Save the Youth, Inc., is facing four felony counts of tax evasion and one count of perjury after an investigation led by the Marion County Prosecutor's Office.

Read More

Indianapolis doctor gets 10 years for drug charges

A judge has sentenced an Indianapolis doctor to 10 years in prison for writing illicit prescriptions for powerful painkillers after the Drug Enforcement Administration had suspended his authority to dispense controlled substances.

Read More

Irsay formally charged with two misdemeanors

Police had filed four preliminary felony counts of possession of a controlled substance, stemming from his intoxicated driving arrest near his home in March. Prosecutors took weeks before deciding to file the misdemeanor charges instead.

Read More

Ex-Lilly partner wins latest suit over Actos’ cancer risk

Takeda Pharmaceutical was found not liable for the bladder cancer of two women who used its Actos diabetes medication in the company’s latest trial over the drug. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.

Read More